Suppr超能文献

相似文献

1
Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study.
Br J Gen Pract. 2020 Feb 27;70(692):e155-e163. doi: 10.3399/bjgp20X708197. Print 2020 Mar.
2
The value of pharmacists in general practice: perspectives of general practitioners-an exploratory interview study.
Int J Clin Pharm. 2019 Apr;41(2):496-503. doi: 10.1007/s11096-019-00795-6. Epub 2019 Mar 12.
3
Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care.
Br J Gen Pract. 2019 Mar;69(680):e190-e198. doi: 10.3399/bjgp19X701321. Epub 2019 Feb 11.
5
Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.
Health Soc Care Community. 2019 May;27(3):565-598. doi: 10.1111/hsc.12618. Epub 2018 Jul 26.
6
General practitioners' perceptions of pharmacists' new services in New Zealand.
Int J Clin Pharm. 2012 Apr;34(2):364-73. doi: 10.1007/s11096-012-9617-3. Epub 2012 Feb 23.
8
Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists.
Int J Pharm Pract. 2014 Feb;22(1):28-37. doi: 10.1111/ijpp.12047. Epub 2013 Jun 11.
9

引用本文的文献

1
Barriers to Community Pharmacists' Prescribing Role in Limpopo Province, South Africa: A Qualitative Study.
Rwanda J Med Health Sci. 2024 Jul 31;7(2):106-119. doi: 10.4314/rjmhs.v7i2.1. eCollection 2024 Jul.
2
Interdisciplinary medication reviews of psychiatric patients - A mixed method evaluation.
Explor Res Clin Soc Pharm. 2025 Mar 2;18:100584. doi: 10.1016/j.rcsop.2025.100584. eCollection 2025 Jun.
5
Development of a medication review intervention by seconding a hospital pharmacist to primary care.
Explor Res Clin Soc Pharm. 2024 Sep 10;16:100505. doi: 10.1016/j.rcsop.2024.100505. eCollection 2024 Dec.
6
Community pharmacists' comfort levels with and barriers to application of an expanded scope of practice in Québec.
Can Pharm J (Ott). 2024 Jul 30;157(5):246-260. doi: 10.1177/17151635241264517. eCollection 2024 Sep-Oct.
10
Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.
Drug Saf. 2024 Jan;47(1):103-111. doi: 10.1007/s40264-023-01362-9. Epub 2023 Nov 2.

本文引用的文献

1
Deprescribing: a primary care perspective.
Eur J Hosp Pharm. 2017 Jan;24(1):37-42. doi: 10.1136/ejhpharm-2016-000967.
2
Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care.
Br J Gen Pract. 2019 Mar;69(680):e190-e198. doi: 10.3399/bjgp19X701321. Epub 2019 Feb 11.
3
Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach.
Lancet. 2018 Jul 7;392(10141):41-50. doi: 10.1016/S0140-6736(18)31308-4. Epub 2018 Jun 29.
5
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.
Age Ageing. 2015 Mar;44(2):213-8. doi: 10.1093/ageing/afu145. Epub 2014 Oct 16.
7
Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists.
Int J Pharm Pract. 2014 Feb;22(1):28-37. doi: 10.1111/ijpp.12047. Epub 2013 Jun 11.
9
Further challenges to medical dominance? The case of nurse and pharmacist supplementary prescribing.
Health (London). 2012 Mar;16(2):115-33. doi: 10.1177/1363459310364159. Epub 2011 Jan 13.
10
Community pharmacist perceptions of clinical medication reviews.
J Prim Health Care. 2010 Sep 1;2(3):234-42.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验